Export

Irinotecan
Essential medicine status
General description
Irinotecan is an antineoplastic topoisomerase I inhibitor used in the treatment of colorectal cancer.
INN
Irinotecan
Medicine type
Chemical agent
EML status history
Therapeutic equivalent for
Wikipedia
DrugBank
Recommendations
Section
Cytotoxic medicines
  • Parenteral > General injections > IV: 40 mg per 2 mL in 2 mL vial; 100 mg per 5 mL in 5 mL vial; 500 mg per 25 mL in 25 mL vial